Literature DB >> 7373218

Synthesis and release of erythroid colony- and burst-potentiating activities by purified populations of murine peritoneal macrophages.

J I Kurland, P A Meyers, M A Moore.   

Abstract

We investigated the effects of murine resident peritoneal macrophages on the in vitro proliferation of erythropoietin (Ep)-sensitive committed precursors colony-forming unit-erythroid (CFU-E) and burst-forming unit-erythroid (BFU-E) with a two-layer cloning system of methylcellulose and semisolid agar. The addition of increasing numbers of macrophages to the agar underlayer resulted in a progressive increase in the numbers of both CFU-E and BFU-E that proliferated in the presence of Ep. CFU-E, but not BFU-E, proliferated to form colonies in the absence Qf exogenously added Ep, and this proliferation was enhanced in a dose-dependent fashion by the presence of macrophages in the underlayer. The enhancing effects of a given number of macrophages and a given concentration of Ep were greater than the sum of the individual effects of macrophages and Ep alone. This erythropoietic syngerism was more evident with BFU-E because burst formation was not seen in the absence of exogenously added Ep. Macrophage underlayers stimulated three to five times the number of erythroid bursts seen with Ep alone. Cell-free agar underlayers or agar underlayers prepared with nonadherent peritoneal cells or unseparated cells from thymus, lymph node, or spleen failed to augment Ep- dependent erythroid colony formation. No enhancement of CFU-E or BFU-E was demonstrable after depletion ofadherent cells from peritoneal cell suspensions by passage over columns of Sephadex G-10. Analysis by sedimentation velocity of peritoneal cells confirmed that the cells responsible for elaborating the erythroid-enhancing activity were macrophages on the basis of morphologic, histochemical, and functional criteria. Serum- free media conditioned by macrophages in the absence of Ep contained the erythroid-enhancing activities, which indicated that Ep was not required for the elaboration of these diffusible substances. These studies indicate that although macrophages are not obligate for the growth of erythroid precursors, they serve as an important source of diffusible factors that reduce the in vitro requirement for Ep.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373218      PMCID: PMC2185833          DOI: 10.1084/jem.151.4.839

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Study of haemopoietic microenvironment in vitro.

Authors:  G E Van Zant; E Goldwasser; J M Baron
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

2.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

3.  Hematopoietic colony formation in a macrophage layer provided by intraperitoneal insertion of cellulose acetate membrane.

Authors:  M Seki
Journal:  Transplantation       Date:  1973-12       Impact factor: 4.939

4.  Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro.

Authors:  J R Stephenson; A A Axelrad; D L McLeod; M M Shreeve
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

5.  Effects of anti-inflammatory drugs on prostaglandin biosynthesis.

Authors:  R Flower; R Gryglewski; K Herbaczyńska-Cedro; J R Vane
Journal:  Nat New Biol       Date:  1972-07-26

6.  Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A.

Authors:  N N Iscove; F Sieber; K H Winterhalter
Journal:  J Cell Physiol       Date:  1974-04       Impact factor: 6.384

7.  Enhancement of erythropoiesis by prostaglandins.

Authors:  P P Dukes; N A Shore; D Hammond; J A Ortega; M C Datta
Journal:  J Lab Clin Med       Date:  1973-11

8.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

9.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

10.  Erythropoietin sensitivity as a differentiation marker in the hemopoietic system: studies of three erythropoietic colony responses in culture.

Authors:  C J Gregory
Journal:  J Cell Physiol       Date:  1976-10       Impact factor: 6.384

View more
  7 in total

Review 1.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 2.  Macrophages: progress and problems.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

3.  Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.

Authors:  M A Smith; S M Knight; P J Maddison; J G Smith
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

4.  Human erythroid burst-forming units. Growth in vitro is dependent on monocytes, but not T lymphocytes.

Authors:  K S Zuckerman
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

5.  Clinicopathologic features of young and old sphha/sphha mice. Mutants with congenital hemolytic anemia.

Authors:  L Maggio-Price; R Russell; N S Wolf; C E Alpers; D Engel
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

6.  Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.

Authors:  Y Ueki; M Nagata; S Miyake; Y Tominaga
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

7.  Hypoxia-inducible factor 1α is Essential for Macrophage-mediated Erythroblast Proliferation in Acute Friend Retrovirus Infection.

Authors:  Timm Schreiber; Theresa Quinting; Ulf Dittmer; Joachim Fandrey; Kathrin Sutter
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.